Please login to the form below

Not currently logged in
Email:
Password:

Xiaflex

This page shows the latest Xiaflex news and features for those working in and with pharma, biotech and healthcare.

Endo tries to ride out Valeant with $15.7bn bid for Salix

Endo tries to ride out Valeant with $15.7bn bid for Salix

a $2.6bn deal that added specialty medicine Xiaflex for fibrotic conditions affecting the fingers and penis. .

Latest news

  • Endo to acquire Auxilium for $2.6bn Endo to acquire Auxilium for $2.6bn

    Auxilium's lead product is Xiaflex (collagenase clostridium histolyticum), which is approved in Europe for the treatment of Dupuytren's contracture, a condition that causes one or more fingers to bend ... We intend to leverage Auxilium's leading presence

  • Endo's $2.2bn bid for Auxilium Pharma could thwart QLT deal Endo's $2.2bn bid for Auxilium Pharma could thwart QLT deal

    Auxilium has 12 approved products in its portfolio, including a range of testosterone supplements headed by Testim Gel, as well as Xiaflex (collagenase clostridium histolyticum) for Dupuytren's contracture - a condition ... While Auxilium's entire

  • Auxilium's Xiaflex cleared in US for erection disorder Auxilium's Xiaflex cleared in US for erection disorder

    FDA approval to treat Peyronie's disease. The US Food and Drug Administration (FDA) cleared Auxilium Pharmaceutical's Xiaflex product to treat Peyronie's disease, a condition that causes painful curvature ... The company has since signed a deal with

  • Extending the arsenal

    XIAFLEX (Auxilium Pharmaceuticals). Dupuytren's contracture. US. Capsaicin dermal patch. Qutenza (NeurogesX).

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics